Extensive product development planning
Dr Stephen Page, a leading veterinary pharmacologist, with a successful background with big pharma, kick starts the pre-clinical studies of Luoda’s pipeline
BioSA grant to support novel dairy unit experiment
Awarded $50,000 to support the development of experimental dairy at University of Adelaide’s Roseworthy Campus
Australian Research Council (ARC) Linkage Grant
Grant worth over $500,000 to help find solutions to the issue of antibiotic resistance in animal health
Patent application: Pimobendan Liquid Formulation
Examination phase of the international patent commences globally.
Patent application: microbial infection treatments
Patent applications submitted to protect the use of ionophores for the treatment of mastitis in dairy cattle and skin infections in dogs
Distribution & Development agreement signed
Major agreement with a Top 10 Global Pharmaceutical company for the commercialisation of an oral solution of the canine cardiac drug pimodendan
Over $2m seed capital already invested in R&D
A recent second fund raise has put Luoda in a position where its current portfolio is fully-funded.
Registration dossier submitted to APVMA
Pimobendan liquid formulation becomes Luoda’s first submission to APVMA for registered status
Pimobendan oral solution approved by APVMA and sales as VETMEDIN ORAL SOLUTION commence soon afterwards.